The Clinical Research of the Effect of Dacronin Gargle on Endotracheal Intubation Response under General Anesthesia

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2100044116

Enrollment

Unknown

Registered

2021-03-11

Start date

2021-09-30

Completion date

Unknown

Last updated

2021-07-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Endotracheal Intubation

Interventions

experimental group:Dacronin Gargle

control group:Nil

Eligibility

Sex/Gender

All

Age

18 Years to 60 Years

Inclusion criteria

Inclusion criteria: The ASA class I~II, anesthesia patients undergoing elective surgery, aged 18 to 60 years.

Exclusion criteria

Exclusion criteria: Nearly six months after myocardial infarction, heart failure, asthma airway hyperresponsiveness, and organic heart disease, within 7 days of the upper respiratory infections.

Design outcomes

Primary

Measure	Time frame
MAP;HR;SpO2;bucking;	—

Countries

China

Contacts

Public ContactChen Ying

the Second Affiliated Hospital of Kunming Medical University

15559672131@163.com+86 15877967204

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026